Cleared Traditional

K800613 - ANGIOPLASTY INJECTOR

K800613 is an FDA 510(k) clearance for ANGIOPLASTY INJECTOR, manufactured by Medrad, Inc.. The device is a Class 2 Cardiovascular device with product code DXT cleared through the Traditional 510(k) pathway after a 21-day FDA review.

K800613 · Medrad, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1980
Decision
21d
Days
Class 2
Risk

K800613 is an FDA 510(k) clearance for the ANGIOPLASTY INJECTOR. Classified as Injector And Syringe, Angiographic (product code DXT), Class II - Special Controls.

Submitted by Medrad, Inc. (Mchenry, US). The FDA issued a Cleared decision on April 8, 1980 after a review of 21 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1650 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medrad, Inc. devices

FDA 510(k) Submission Details - K800613

510(k) Number K800613 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 18, 1980
Decision Date April 08, 1980
Days to Decision 21 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
104d faster than avg
Panel avg: 125d · This submission: 21d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXT Device Classification - Class 2, Special Controls

Product Code DXT Injector And Syringe, Angiographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1650
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXT Injector And Syringe, Angiographic

All 168
Devices cleared under the same product code (DXT) and FDA review panel - the closest regulatory comparables to K800613.
CLEAR VINYL MONITORING CONNECTOR
K823340 · Vertex Medical Corp. · Dec 1982
MARK V
K822536 · Medrad, Inc. · Sep 1982
QUICK FILL
K800823 · Medrad, Inc. · Apr 1980
USCI BALLOON DILATATION INFLATION DEV.
K791782 · C.R. Bard, Inc. · Dec 1979
USCI PRESSURE GAUGE
K791793 · C.R. Bard, Inc. · Dec 1979
DISPOSABLE SYRINGE FILL TUBE
K781334 · Mallinckrodt Group, Inc. · Aug 1978